← SynDRA
Acteoside
SynDRA canonical compound SYN1953383 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
|---|
| Mechanism of action | NFkB pathway inhibitor | PKC inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- TRPV3 INHIBITOR
- PRKCA INHIBITOR
Drug classes
- Anti-Infective Agents
- Antineoplastic Agents, Phytogenic
- Antioxidants
- Chelating Agents
- Immunosuppressive Agents
Cross-references
Synonyms
- TJC-160
- Verbascoside
- Kusaginin
- 3TGX09BD5B
- CHEBI:132853
- NSC 603831
- RefChem:51015
- DTXCID101506860
- Verbacoside
- acetoside
- MFCD00221751
- C29H36O15
- UNII-3TGX09BD5B
- Reh-acteoside
- RUSSETINOL
- STEREOSPERMIN
- Acteoside; Verbascoside
- Verbascoside (Standard)
- Acetoside (Verbascoside)
- Verbascoside [WHO-DD]
- MLS002473233
- SCHEMBL657970
- VERBASCOSIDE [USP-RS]
- orb1304265
- orb3140367
- SCHEMBL29485048
- SCHEMBL29499087
- SCHEMBL29626822
- cid_5281800
- GTPL12550
- HY-N0021R
- Verbascoside, >=99% (HPLC)
- cid_24978601
- GLXC-07496
- HMS2205K11
- HY-N0021
- BDBM50241867
- MSK000876
- s5458
Look up Acteoside in the interactive SynDRA portal →